Dear Friends,
Due to the recent hurricane we are going to postpone tomorrow's MD STARnet webinar.
We will be in touch regarding the new date. Sorry for the inconvenience.
Best,
Ryan Fischer
PPMD
Added by PPMD on October 30, 2012 at 1:00pm — No Comments
New release from Prosensa:
£10m in milestone payments received from GlaxoSmithKline
Leiden, The Netherlands, 23 October 2012 – Prosensa, the Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet need, has selected clinical candidates for two more compounds for the treatment of Duchenne muscular dystrophy (DMD) and has been granted…
ContinueAdded by PPMD on October 23, 2012 at 12:35pm — 2 Comments
Dr. Jerry Mendell, Director of the Centers for Gene Therapy and Muscular Dystrophy at Nationwide Children's Hospital and principal investigator of the Phase IIb eteplirsen study, presented the full set of 48-week data from…
Added by PPMD on October 16, 2012 at 9:00am — No Comments
2018
2017
2016
2015
2014
2013
2012
2011
2010
© 2021 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service